Success Stories
Highlights of the PCI news focused on Penn commercialization accomplishments
PCI programming goes virtual
Throughout FY21, the PCI full suite of programming from I-Corps and Fellows training to our speaker series, were hosted entirely online.
Neuralert achieves a key milestone
Neuralert is developing a novel invention that addresses the problem of late or undetected stroke in hospitalized patients.
Verismo launches with CAR-T expert co-founders
Verismo, a new cell therapy company pioneering multi-chain CAR-T technology, raised $16 million in equity financing.
G2Bio launches with $200M to invest in research and development of novel gene therapies
The G2 Bio Companies, founded by James M. Wilson and the late Tachi Yamada, launched with a $200 million investment commitment from the global investment firm Temasek.
School of Veterinary Medicine faculty form a key biotech partnership
Iveric Bio entered into a sponsored research agreement with Drs. Karina Guziewicz and William Beltran both from the School of Veterinary Medicine.
Freddie Mac partners with Wharton faculty to understand regulations on housing affordability
Wharton Professor Susan Wachter is working with Freddie Mac to address the nation’s crisis of housing affordability which is worsening over time.
AbbVie partners with Penn Chemistry and the Molander Lab
AbbVie has entered into two Sponsored Research Agreements with the lab of Gary Molander, PhD, Professor of Chemistry in the School of Arts & Sciences.
Cancer technology leads to a new startup
Awarded a patent that describes novel autophagy inhibitors potentially useful in cancer therapy.
Gene therapy pioneer invents new therapy to improve delivery of gene therapies to treat ocular diseases
Awarded a patent that describes mRNA trans-splicing as a gene therapy for treatment of ocular diseases caused by defects in large genes.